PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.1184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases From Advanced Breast Cancer in Chinese Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Neoadjuvant Chemotherapy With Zoledronic Acid for HER2-Negative Breast Cancer in Japan: The JONIE1 Study

Health
2019English

Cost-Effectiveness of Using Prognostic Information to Select Women With Breast Cancer for Adjuvant Systemic Therapy

Health Technology Assessment
MedicineHealth Policy
2006English

Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil

Revista da Associacao Medica Brasileira
Medicine
2009English

Perspectives of Postmenopausal Breast Cancer Survivors on Adjuvant Endocrine Therapy-Related Symptoms

Oncology Nursing Forum
Oncology
2014English

Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Clinical Cancer Research
Cancer ResearchOncology
2009English

Lifetime Cost-Effectiveness of Adjuvant External Beam Whole Breast Irradiation (EBWBI) in Estrogen Receptor Positive (ER+) Early-Stage Breast Cancer (ESBC) Women: Cardiotoxicity Consideration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy